Showing results (161-170 of 244) with videos related to
Sort By:
Pageof 25
Journal of Hepatology|April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agentXavier Forns, Stuart C Gordon, Eli Zuckerman, et al.Annals of Internal Medicine|April 16, 2003
Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosisElizabeth D Morrison, David J Brandhagen, Pradyumna D Phatak, et al.Hepatology (Baltimore, Md.)|August 19, 2014
Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for interventionAnne C Moorman, Jian Xing, Stephen Ko, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2017
Changing trends in complications of chronic hepatitis CMei Lu, Jia Li, Loralee B Rupp, et al.Alimentary Pharmacology & Therapeutics|January 17, 2019
Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetesJia Li, Stuart C Gordon, Loralee B Rupp, et al.The New England Journal of Medicine|April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infectionBruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.The American Journal of Gastroenterology|July 29, 2015
Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational studyStuart C Gordon, Lois E Lamerato, Loralee B Rupp, et al.Journal of Clinical Gastroenterology|November 2, 2013
Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic responseStuart C Gordon, K Rajender Reddy, Ira M Jacobson, et al.Journal of Viral Hepatitis|June 15, 2019
Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failureMei Lu, Kuan-Han Wu, Jia Li, et al.Journal of Clinical Gastroenterology|July 25, 2017
Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United StatesStuart C Gordon, Sheri Trudeau, Jia Li, et al.Pageof 25